Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Saccomano Nicholas A
President and CEO at OnKure Therapeutics. Filing since 4 Apr 2025.
CIK 0001609284
Company
Date
Role
Action
Shares
Amount
Of holding
OKUR
OnKure Therapeutics, Inc.
21 Sep 2026
President and CEO
Sold at will
87
$258.76
0.8%
OKUR
OnKure Therapeutics, Inc.
22 Jun 2026
President and CEO
Sold at will
86
$378.08
0.8%
OKUR
OnKure Therapeutics, Inc.
23 Mar 2026
President and CEO
Sold at will
86
$357.46
1.2%
OKUR
OnKure Therapeutics, Inc.
22 Dec 2025
President and CEO
Sold at will
87
$258.19
1.2%
OKUR
OnKure Therapeutics, Inc.
22 Sep 2025
President and CEO
Sold at will
88
$230.87
2.4%
OKUR
OnKure Therapeutics, Inc.
23 Jun 2025
President and CEO
Sold at will
88
$209.81
2.4%
OKUR
OnKure Therapeutics, Inc.
7 Apr 2025
President and CEO
Sold at will
516
$1.38K
12.3%
OKUR
OnKure Therapeutics, Inc.
4 Apr 2025
President and CEO
Sold at will
358
$1.19K
7.9%
8 decisions on file.
